| # | Title | Journal | Year | Citations |
|---|
| 1 | Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder | BJU International | 2004 | 352 |
| 2 | EAU Guidelines on Urinary Incontinence | European Urology | 2011 | 310 |
| 3 | Detrusor Underactivity and the Underactive Bladder: A New Clinical Entity? A Review of Current Terminology, Definitions, Epidemiology, Aetiology, and Diagnosis | European Urology | 2014 | 303 |
| 4 | The ICS-‘BPH’ Study: the psychometric validity and reliability of the ICSmale questionnaire | British Journal of Urology | 1996 | 263 |
| 5 | Silodosin Therapy for Lower Urinary Tract Symptoms in Men with Suspected Benign Prostatic Hyperplasia: Results of an International, Randomized, Double-Blind, Placebo- and Active-Controlled Clinical Trial Performed in Europe | European Urology | 2011 | 245 |
| 6 | Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro | British Journal of Pharmacology | 2000 | 232 |
| 7 | A Contemporary Assessment of Nocturia: Definition, Epidemiology, Pathophysiology, and Management—a Systematic Review and Meta-analysis | European Urology | 2012 | 231 |
| 8 | Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability | Neurourology and Urodynamics | 2014 | 228 |
| 9 | Buccal mucosal urethroplasty: is it the new gold standard? | BJU International | 2004 | 191 |
| 10 | Defining a Patient-Reported Outcome Measure for Urethral Stricture Surgery | European Urology | 2011 | 170 |
| 11 | Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice | European Urology | 2017 | 162 |
| 12 | Behavior of Urothelial Carcinoma With Respect to Anatomical Location | Journal of Urology | 2007 | 156 |
| 13 | The minor population of M3-receptors mediate contraction of human detrusor muscle in vitro | Autonomic and Autacoid Pharmacology | 2001 | 152 |
| 14 | The changing pattern of mortality and morbidity from radical cystectomy | BJU International | 2000 | 147 |
| 15 | β3-Adrenoceptors in urinary bladder | Neurourology and Urodynamics | 2007 | 146 |
| 16 | Generalised Increase in Bone Resorption in Carcinoma of the Prostate | British Journal of Urology | 1985 | 141 |
| 17 | The pharmacological treatment of urinary incontinence | BJU International | 2001 | 141 |
| 18 | Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study) | BJU International | 2017 | 132 |
| 19 | The Underactive Bladder: A New Clinical Concept? | European Urology | 2015 | 123 |
| 20 | Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia | British Journal of Cancer | 1994 | 122 |
| 21 | A phase II dose-ranging study of mirabegron in patients with overactive bladder | International Urogynecology Journal | 2013 | 121 |
| 22 | Muscarinic receptor subtypes and management of the overactive bladder | Urology | 2002 | 117 |
| 23 | CONVENTIONAL AND AMBULATORY URODYNAMIC FINDINGS IN WOMEN WITH SYMPTOMS SUGGESTIVE OF BLADDER OVERACTIVITY | Journal of Urology | 2001 | 109 |
| 24 | Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received | European Urology | 2020 | 107 |
| 25 | Tissue-engineered buccal mucosa for substitution urethroplasty | BJU International | 2004 | 106 |
| 26 | The effects of tamsulosin, a high affinity antagonist at functional α 1A - and α 1D -adrenoceptor subtypes | British Journal of Pharmacology | 1997 | 102 |
| 27 | Which muscarinic receptor is important in the bladder? | World Journal of Urology | 2001 | 98 |
| 28 | Surgical Techniques in Substitution Urethroplasty Using Buccal Mucosa for the Treatment of Anterior Urethral Strictures | European Urology | 2008 | 97 |
| 29 | Systematic Review of Combination Drug Therapy for Non-neurogenic Male Lower Urinary Tract Symptoms | European Urology | 2013 | 97 |
| 30 | Epidemiology, aetiology and screening of bladder cancer | Translational Andrology and Urology | 2019 | 97 |
| 31 | A Systematic Review of Surgical Techniques Used in the Treatment of Female Urethral Stricture | European Urology | 2013 | 94 |
| 32 | Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician | BJU International | 2004 | 91 |
| 33 | Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study | Journal of Urology | 2016 | 87 |
| 34 | Alpha1-adrenoceptor subtypes in the human prostate | British Journal of Urology | 1994 | 84 |
| 35 | T1 Bladder Tumours | British Journal of Urology | 1977 | 82 |
| 36 | A proof‐of‐concept study: Mirabegron, a new therapy for overactive bladder | Neurourology and Urodynamics | 2013 | 82 |
| 37 | Prevalence of Lower Urinary Tract Symptoms in China, Taiwan, and South Korea: Results from a Cross-Sectional, Population-Based Study | Advances in Therapy | 2017 | 82 |
| 38 | The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia | British Journal of Urology | 1994 | 80 |
| 39 | Bladder and erectile dysfunction before and after rectal surgery for cancer | British Journal of Urology | 1995 | 80 |
| 40 | Cardiovascular Safety of β3-adrenoceptor Agonists for the Treatment of Patients with Overactive Bladder Syndrome | European Urology | 2016 | 80 |
| 41 | Fertility after Torsion of the Spermatic Cord | British Journal of Urology | 1990 | 78 |
| 42 | In vitro α1 -adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel α 1A -adrenoceptor selective antagonists | British Journal of Pharmacology | 1999 | 77 |
| 43 | Medical Consumption and Costs during a One-Year Follow-up of Patients with LUTS Suggestive of BPH in Six European Countries: Report of the TRIUMPH Study | European Urology | 2006 | 77 |
| 44 | A Prospective Patient-centred Evaluation of Urethroplasty for Anterior Urethral Stricture Using a Validated Patient-reported Outcome Measure | European Urology | 2013 | 76 |
| 45 | Detrusor Underactivity and the Underactive Bladder: A Systematic Review of Preclinical and Clinical Studies | European Urology | 2018 | 74 |
| 46 | Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma | Journal of Pathology | 2006 | 73 |
| 47 | The role of M2 -muscarinic receptors in mediating contraction of the pig urinary bladder in vitro | British Journal of Pharmacology | 2000 | 71 |
| 48 | Safety and tolerability of the β 3 ‐adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12‐week randomised Phase III trials and of a 1‐year randomised Phase III trial | International Journal of Clinical Practice | 2014 | 70 |
| 49 | Circulating Prostate Specific Antigen‐positive Cells Correlate with Metastatic Prostate Cancer | British Journal of Urology | 1992 | 69 |
| 50 | Long‐term follow‐up of a multicentre randomised controlled trial comparing tension‐free vaginal tape, xenograft and autologous fascial slings for the treatment of stress urinary incontinence in women | BJU International | 2015 | 69 |
